241 related articles for article (PubMed ID: 25598973)
21. The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy.
Shao A; Owens DM
Oncotarget; 2023 Feb; 14():96-103. PubMed ID: 36738455
[TBL] [Abstract][Full Text] [Related]
22. Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma.
Olin MR; Ampudia-Mesias E; Pennell CA; Sarver A; Chen CC; Moertel CL; Hunt MA; Pluhar GE
Cancers (Basel); 2019 Jan; 11(2):. PubMed ID: 30682795
[TBL] [Abstract][Full Text] [Related]
23. The Role of CD200-CD200 Receptor in Human Blood and Lymphatic Endothelial Cells in the Regulation of Skin Tissue Inflammation.
Rütsche D; Michalak-Micka K; Zielinska D; Moll H; Moehrlen U; Biedermann T; Klar AS
Cells; 2022 Mar; 11(6):. PubMed ID: 35326506
[TBL] [Abstract][Full Text] [Related]
24. A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma.
Liu JQ; Talebian F; Wu L; Liu Z; Li MS; Wu L; Zhu J; Markowitz J; Carson WE; Basu S; Bai XF
J Immunol; 2016 Aug; 197(4):1489-97. PubMed ID: 27385779
[TBL] [Abstract][Full Text] [Related]
25. CD200-CD200R signaling and diseases: a potential therapeutic target?
Ngwa C; Liu F
Int J Physiol Pathophysiol Pharmacol; 2019; 11(6):297-309. PubMed ID: 31993106
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of CD200 is a Stem Cell-Specific Mechanism of Immune Evasion in AML.
Herbrich S; Baran N; Cai T; Weng C; Aitken MJL; Post SM; Henderson J; Shi C; Richard-Carpentier G; Sauvageau G; Baggerly K; Al-Atrash G; Davis RE; Daver N; Zha D; Konopleva M
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34326171
[TBL] [Abstract][Full Text] [Related]
27. CD200 positive human mesenchymal stem cells suppress TNF-alpha secretion from CD200 receptor positive macrophage-like cells.
Pietilä M; Lehtonen S; Tuovinen E; Lähteenmäki K; Laitinen S; Leskelä HV; Nätynki A; Pesälä J; Nordström K; Lehenkari P
PLoS One; 2012; 7(2):e31671. PubMed ID: 22363701
[TBL] [Abstract][Full Text] [Related]
28. CD200R signaling contributes to unfavorable tumor microenvironment through regulating production of chemokines by tumor-associated myeloid cells.
Lin CH; Talebian F; Li Y; Zhu J; Liu JQ; Zhao B; Basu S; Pan X; Chen X; Yan P; Carson WE; Xin G; Wen H; Wang R; Li Z; Ma Q; Bai XF
iScience; 2023 Jun; 26(6):106904. PubMed ID: 37275530
[TBL] [Abstract][Full Text] [Related]
29. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
[TBL] [Abstract][Full Text] [Related]
30. Mathematical Modeling and Analysis of CD200-CD200R in Cancer Treatment.
Liao KL; Watt KD
Bull Math Biol; 2022 Jul; 84(8):82. PubMed ID: 35792958
[TBL] [Abstract][Full Text] [Related]
31. Regulation of myeloid cell function through the CD200 receptor.
Jenmalm MC; Cherwinski H; Bowman EP; Phillips JH; Sedgwick JD
J Immunol; 2006 Jan; 176(1):191-9. PubMed ID: 16365410
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation.
Walker DG; Dalsing-Hernandez JE; Campbell NA; Lue LF
Exp Neurol; 2009 Jan; 215(1):5-19. PubMed ID: 18938162
[TBL] [Abstract][Full Text] [Related]
33. Newly Formed Endothelial Cells Regulate Myeloid Cell Activity Following Spinal Cord Injury via Expression of CD200 Ligand.
Cohen M; Ben-Yehuda H; Porat Z; Raposo C; Gordon S; Schwartz M
J Neurosci; 2017 Jan; 37(4):972-985. PubMed ID: 28123029
[TBL] [Abstract][Full Text] [Related]
34. CD200 and CD200R Expression on Peripheral Blood Lymphocytes and Serum CD200 Concentration as a New Marker of Endometriosis.
Abramiuk M; Grywalska E; Korona-Głowniak I; Niedźwiedzka-Rystwej P; Polak G; Kotarski J; Roliński J
J Clin Med; 2020 Sep; 9(9):. PubMed ID: 32967175
[TBL] [Abstract][Full Text] [Related]
35. Regulation of microglial cell responses in murine Toxoplasma encephalitis by CD200/CD200 receptor interaction.
Deckert M; Sedgwick JD; Fischer E; Schlüter D
Acta Neuropathol; 2006 Jun; 111(6):548-58. PubMed ID: 16718351
[TBL] [Abstract][Full Text] [Related]
36. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
Deng Y; Cheng J; Fu B; Liu W; Chen G; Zhang Q; Yang Y
Oncogene; 2017 Feb; 36(8):1090-1101. PubMed ID: 27593937
[TBL] [Abstract][Full Text] [Related]
37. CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy.
Kretz-Rommel A; Qin F; Dakappagari N; Ravey EP; McWhirter J; Oltean D; Frederickson S; Maruyama T; Wild MA; Nolan MJ; Wu D; Springhorn J; Bowdish KS
J Immunol; 2007 May; 178(9):5595-605. PubMed ID: 17442942
[TBL] [Abstract][Full Text] [Related]
38. The immune inhibitory complex CD200/CD200R is developmentally regulated in the mouse brain.
Shrivastava K; Gonzalez P; Acarin L
J Comp Neurol; 2012 Aug; 520(12):2657-75. PubMed ID: 22323214
[TBL] [Abstract][Full Text] [Related]
39. Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200.
Moon SY; Han M; Ryu G; Shin SA; Lee JH; Lee CS
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894750
[TBL] [Abstract][Full Text] [Related]
40. [CD200/CD200R Expression Levels and Its Significance after Allogeneic Hematopoietic Stem Cell Transplantation].
Huang YH; Zhang W; Cai H; Li TJ; Li J; Han B; Zhuang JL; Zhu TN; Cai HC; Zhou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):815-20. PubMed ID: 27342516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
